Division of Pharmaceutical Product Development Inc.
Latest From InnoPharm Ltd.
The JOBS Act allows young companies to make their pitch openly to hundreds of thousands of wealthy individuals who rarely invest in private life sciences companies. Can Poliwogg’s new web site connect them, and bridge the funding gap between foundations and VCs?
The New York-based company has new relationships with a pair of disease foundations and a veteran venture investor. Its Web platform is designed to connect micro-investors with projects of interest, in a fashion enabled by new provisions of the JOBS Act.
Companies are sprouting across the pharma value chain that harness the voices of patients and other individual stakeholders to drive the research, development, and financing of drugs. Pharma is taking tentative steps toward using these methods, but high barriers remain to their systematic integration in R&D.
Transparency Life Sciences applies crowdsourcing to the design of clinical protocols with the aim of lowering costs and improving outcomes for clinical trials. The company won FDA clearance for its first IND based on a protocol that resulted from its process and is securing its first financing.
- Contract Research, Toxicology Testing-CRO
- Therapeutic Areas
- Eastern Europe
- Parent & Subsidiaries
- Pharmaceutical Product Development Inc.
- Senior Management
- Vladimir Krechikov, Mgr., Bus. Dev.
- Contact Info
Phone: (7) 4812 31 5335
P.O. Box 57 Smolensk, 214019
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.